Josep Mallolas

10.0k total citations
224 papers, 5.5k citations indexed

About

Josep Mallolas is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Josep Mallolas has authored 224 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Infectious Diseases, 84 papers in Epidemiology and 79 papers in Virology. Recurrent topics in Josep Mallolas's work include HIV/AIDS drug development and treatment (99 papers), HIV Research and Treatment (78 papers) and HIV/AIDS Research and Interventions (64 papers). Josep Mallolas is often cited by papers focused on HIV/AIDS drug development and treatment (99 papers), HIV Research and Treatment (78 papers) and HIV/AIDS Research and Interventions (64 papers). Josep Mallolas collaborates with scholars based in Spain, United States and United Kingdom. Josep Mallolas's co-authors include Estebán Martínez, José Luís Blanco, Elisa de Lazzari, José M. Gatell, Montserrat Laguno, Ana Milinkovic, Agathe León, Montserrat Loncà, María Larrousse and Josep M. Gatell and has published in prestigious journals such as The Lancet, Gastroenterology and PLoS ONE.

In The Last Decade

Josep Mallolas

212 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josep Mallolas Spain 40 3.2k 2.3k 1.5k 1.5k 1.1k 224 5.5k
Marina B. Klein Canada 47 2.7k 0.9× 3.6k 1.5× 1.1k 0.7× 2.7k 1.8× 916 0.9× 288 6.6k
Lionel Piroth France 37 2.1k 0.7× 2.0k 0.8× 519 0.3× 1.1k 0.7× 708 0.7× 208 4.5k
Antonio Rivero Spain 40 2.6k 0.8× 3.3k 1.4× 749 0.5× 2.7k 1.8× 439 0.4× 307 6.3k
Pablo Barreiro Spain 46 3.6k 1.1× 3.8k 1.6× 1.6k 1.0× 3.7k 2.4× 964 0.9× 331 7.3k
Kiat Ruxrungtham Thailand 44 5.4k 1.7× 2.4k 1.0× 3.8k 2.5× 875 0.6× 1.9k 1.8× 322 8.7k
D. Neau France 35 1.7k 0.5× 1.2k 0.5× 1.2k 0.8× 708 0.5× 845 0.8× 152 3.2k
Gregory K. Robbins United States 47 4.2k 1.3× 3.0k 1.3× 4.3k 2.8× 2.4k 1.6× 1.6k 1.5× 143 9.9k
Michael A. Polis United States 43 3.5k 1.1× 2.9k 1.2× 4.3k 2.8× 930 0.6× 832 0.8× 143 8.6k
Milos Opravil Switzerland 42 4.5k 1.4× 2.3k 1.0× 3.6k 2.3× 607 0.4× 1.2k 1.1× 145 7.2k
Félix Gutiérrez Spain 42 3.7k 1.2× 2.2k 0.9× 2.2k 1.4× 349 0.2× 1.7k 1.6× 281 6.5k

Countries citing papers authored by Josep Mallolas

Since Specialization
Citations

This map shows the geographic impact of Josep Mallolas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Mallolas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Mallolas more than expected).

Fields of papers citing papers by Josep Mallolas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Mallolas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Mallolas. The network helps show where Josep Mallolas may publish in the future.

Co-authorship network of co-authors of Josep Mallolas

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Mallolas. A scholar is included among the top collaborators of Josep Mallolas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Mallolas. Josep Mallolas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vergara, Andrea, Iván Chivite, Ana González-Cordón, et al.. (2025). Detection of Neisseria gonorrhoeae and Chlamydia trachomatis by PCR in a sample pool (urine, rectum and pharynx) in asymptomatic patients at risk of sexually transmitted infections. Enfermedades Infecciosas y Microbiología Clínica. 43(7). 374–377.
2.
3.
Mora, Lorena de la, Josep Mallolas, & Juan Ambrosioni. (2024). Epidemiología, tratamiento y pronóstico de la infección VIH en 2024: revisión práctica. Medicina Clínica. 162(11). 535–541. 5 indexed citations
4.
Laguno, Montserrat, Elisa de Lazzari, Alexy Inciarte, et al.. (2024). Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV. HIV Medicine. 25(12). 1308–1324. 1 indexed citations
5.
Mallolas, Josep & Ainoa Ugarte. (2021). Detectar personas que desconocen su infección por VIH en los servicios de urgencias: ¿una utopía?. Emergencias. 33(4). 249–250. 2 indexed citations
6.
Quirós, Carmen, Narcı́s Saubi, Asunción Moreno, et al.. (2018). Full blood count values as a predictor of poor outcome of pneumonia among HIV-infected patients. BMC Infectious Diseases. 18(1). 189–189. 16 indexed citations
7.
Yong, Chan‐Loi, Joseph Gathe, Catherine Orrell, et al.. (2017). Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection. HIV Clinical Trials. 18(5-6). 189–195. 3 indexed citations
8.
Torres, Berta, Agathe León, Marta Calvo, et al.. (2013). Rate and Predictors of Non-AIDS Events in a Cohort of HIV-Infected Patients with a CD4 T Cell Count Above 500 Cells/mm 3. AIDS Research and Human Retroviruses. 29(8). 1161–1167. 37 indexed citations
9.
Mallolas, Josep, Maria Martínez‐Rebollar, & Montserrat Laguno. (2011). Tratamiento de la hepatitis por virus C en pacientes coinfectados por el virus de la inmunodeficiencia humana. Gastroenterología y Hepatología. 34(8). 558–567. 1 indexed citations
10.
Vallecillo, Gabriel, Peré Domingo, Josep Mallolas, et al.. (2011). Evaluation of the Safety and Effectiveness of Nevirapine Plus Coformulated Tenofovir/Emtricitabine as First-Line Therapy in Routine Clinical Practice. AIDS Research and Human Retroviruses. 28(2). 165–170. 2 indexed citations
11.
Laufer, Natalia, Montserrat Laguno, Iñaki Pérez, et al.. (2008). Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin.. PubMed. 13(7). 953–7. 24 indexed citations
12.
Martin, M., Elena del Cacho, Carles Codina, et al.. (2008). Relationship between Adherence Level, Type of the Antiretroviral Regimen, and Plasma HIV Type 1 RNA Viral Load: A Prospective Cohort Study. AIDS Research and Human Retroviruses. 24(10). 1263–1268. 122 indexed citations
13.
Laguno, Montserrat, María Larrousse, José Luís Blanco, et al.. (2008). Prevalence and Clinical Relevance of Occult Hepatitis B in the Fibrosis Progression and Antiviral Response to INF Therapy in HIV–HCV-Coinfected Patients. AIDS Research and Human Retroviruses. 24(4). 547–553. 12 indexed citations
14.
Bitrian, Elena, Ricardo P. Casaroli‐Marano, Alfredo Adán, et al.. (2007). Changes of Retinal Nerve Fiber Layer (RNFL) Thickness in Patients With Human Immunodeficiency Virus (HIV) Treated With Haart :An Oct Study. Investigative Ophthalmology & Visual Science. 48(13). 342–342.
15.
Castro, Pedro, Montserrat Laguno, Meritxell Nomdedéu, et al.. (2007). Clinicoimmunological Progression and Response to Treatment of Long-Term Nonprogressor HIV–Hepatitis C Virus-Coinfected Patients. AIDS Research and Human Retroviruses. 23(7). 863–867. 4 indexed citations
16.
Walker, Ulrich A., Jochen Bäuerle, Montse Laguno, et al.. (2004). Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine. Hepatology. 39(2). 311–317. 123 indexed citations
17.
Rifé, M., Célia Bádenas, Josep Mallolas, et al.. (2003). Incidence of Fragile X in 5,000 Consecutive Newborn Males. Genetic Testing. 7(4). 339–343. 44 indexed citations
18.
Martínez, Estebán, et al.. (2000). A prospective cohort study on the risk for lipodystrophy in HIV-infected patients treated with protease inhibitor-containing regimens.. UCL Discovery (University College London). 1 indexed citations
19.
20.
Jm, Miró, J. Batalla, Josep Mallolas, et al.. (1992). Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients.. PubMed. 5(7). 737–42. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina B. Klein Breakdown of academic impact, for papers by Lionel Piroth Breakdown of academic impact, for papers by Antonio Rivero Breakdown of academic impact, for papers by Pablo Barreiro Breakdown of academic impact, for papers by Kiat Ruxrungtham Breakdown of academic impact, for papers by D. Neau Breakdown of academic impact, for papers by Gregory K. Robbins Breakdown of academic impact, for papers by Michael A. Polis Breakdown of academic impact, for papers by Milos Opravil Breakdown of academic impact, for papers by Félix Gutiérrez
Rankless by CCL
2026